The Nursing Homes Support Scheme (NHSS), commonly referred to as Fair Deal, is a system of financial support for people who require long-term residential care. Participants contribute to the cost of their care according to their means while the State pays the balance of the cost. The Scheme aims to ensure that long-term nursing home care is accessible and affordable for everyone and that people are cared for in the most appropriate settings.
The Report of the NHSS Review published in 2015 identified a number of issues for more detailed consideration, including a review of the pricing mechanism used by the NTPF, with a view to:
- Ensuring value for money and economy, with the lowest possible administrative costs for clients and the State and administrative burden for providers;
- Increasing the transparency of the pricing mechanism so that existing and potential investors can make as informed decisions as possible; and
- Ensuring that there is adequate residential capacity for those residents with more complex needs.
A Steering Group was established to oversee and manage the pricing review. The Steering Group is chaired by the NTPF and includes representatives from the Department of Health and the Department of Public Expenditure and Reform (DPER). As part of its work on the review the NTPF sought various inputs including external expertise and stakeholder engagement to inform the review. These inputs are being considered in detail.
I understand that the NTPF is now close to completing the report and it is expected that the Steering Group will be provided with a final draft very shortly. Once complete the report of the review will then be submitted to the Department of Health.
It is recognised that any change to any part of the Scheme must be considered in terms of the short- and long-term impact on the viability of the Scheme and accessibility of long-term residential care in general. It is therefore important that the relevant issues are considered thoroughly through the review process.